Literature DB >> 11311171

Preferences for treatment during a first psychotic episode.

L de Haan1, B van Raaij, R van den Berg, M Jager, P Houweling, M Stockmann, P Delsing, D Linszen, B Peters, L Wouters.   

Abstract

Psychiatric services providing care for patients and their families confronted with a first psychotic episode need to be sensitive towards patients' and families' preferences. Ten patients, ten family members and ten professional caregivers composed a list of 42 preferences in the treatment for a first psychotic episode. In total 99 patients, 100 family members and 263 professional caregivers evaluated these preferences, thus producing an order of priorities. There appears to be considerable agreement among the groups of respondents regarding their top ten priorities, especially concerning information on diagnosis and medication. However, we found important differences between groups of respondents. The results suggest that in psychiatric services great attention should be given to psycho-education and early outpatient intervention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311171     DOI: 10.1016/s0924-9338(01)00542-9

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  3 in total

1.  Quality assessment of mental health care by people with severe mental disorders: a participatory research project.

Authors:  Angelo Barbato; Alessia Bajoni; Filippo Rapisarda; Vito D'Anza; Luigi Fabrizio De Luca; Cristiana Inglese; Sonia Iapichino; Fabrizio Mauriello; Barbara D'Avanzo
Journal:  Community Ment Health J       Date:  2013-12-08

2.  Service user and family carer involvement in mental health care: divergent views.

Authors:  Else Tambuyzer; Chantal Van Audenhove
Journal:  Community Ment Health J       Date:  2013-01-05

3.  Stakeholder perspective on barrier to the implementation of Advance Care Planning in a traditionally paternalistic healthcare system.

Authors:  Stellar Hiu; Alex Su; Samantha Ong; Daniel Poremski
Journal:  PLoS One       Date:  2020-11-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.